Figure 1. The methodological flowchart of this study.
This study firstly experimentally demonstrated the therapeutic effect of daidzein on osteosarcoma, then through the exploration of network pharmacology and molecular docking technology, key molecules and pathways were targeted and experimentally validated. Website links: DigSeE (Kim et al., 2013), DisGeNET (http://www.disgenet.org/), GeneCards (https://www.genecards.org/) KEGG disease (https://www.kegg.jp/kegg/disease/) MalaCards (http://www.malacards.org/) Phenopedia (https://phgkb.cdc.gov/PHGKB/startPagePhenoPedia.action) PubChem (https://pubchem.ncbi.nlm.nih.gov/) PharmMapper (http://www.lilab-ecust.cn/pharmmapper/) VENNY 2.1.0 (https://bioinfogp.cnb.csic.es/tools/venny/).